002422 科伦药业
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额1,684,4424,492,8625,337,0693,126,9582,847,118
投资活动产生之现金流量净额(1,383,163)(1,819,368)(3,370,325)(857,096)(1,529,790)
筹资活动产生之现金流量净额2,076,953(3,304,276)(2,058,766)(407,261)(1,270,756)
汇率变动对现金及现金等价物的影响(8,626)(12,780)5,1947,934(8,266)
现金及现金等价物净增加/(减少)2,369,607(643,562)(86,828)1,870,53538,306
期初现金及现金等价物余额3,944,7624,588,3244,675,1522,804,6172,761,703
期末现金及现金等价物余额6,314,3693,944,7624,588,3244,675,1522,800,009